JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2004; 44:2307-2314, doi:10.1016/j.jacc.2004.09.037
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feiring, A. J.
Right arrow Articles by Lade, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feiring, A. J.
Right arrow Articles by Lade, S.

Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication

Early and one-year outcomes

Andrew J. Feiring, MD, FACC, FCSAI*, Amy A. Wesolowski, RN and Susan Lade, RN

Columbia-St. Mary's Medical Center, Milwaukee, Wisconsin



View larger version (18K):

[in a new window]
 
Figure 1 Distribution of patients based on success or failure of below-knee stent-supported angioplasty. AMP-CLI = patients with critical limb ischemia (CLI) who subsequently underwent below-knee amputation after multiple failed interventions; PTA-LLC = percutaneous transluminal angioplasty for lifestyle-limiting claudication; TVR = target vessel revascularization.

 


View larger version (112K):

[in a new window]
 
Figure 2 (A) Sixty-year-old diabetic woman. Note the deep, broad-based nonhealing foot ulcer. Despite five months of conservative therapy, the ankle brachial index was 0.42 with a toe pressure of 25 mm Hg. Before vascular intervention she underwent coronary bypass for left main three-vessel coronary disease. (B) Three months after primary stent-supported intervention, aspirin, and clopidogrel, the ulceration demonstrates complete healing that has been maintained for three years. (C) Pre-intervention angiogram demonstrating complete occlusion of the posterior tibial and peroneal arteries and a long subtotal occlusion (solid arrows), of the anterior tibial artery. (D) Post-intervention angiogram after placement of two balloon-expandable coronary Hepacoat (Cordis) stents. One-month resting ankle brachial index normalized to 0.98.

 


View larger version (67K):

[in a new window]
 
Figure 3 (A) Pre-intervention angiogram in a 78-year-old man with lifestyle-limiting claudication and resting ankle brachial index (ABI) of 0.41. Note the total occlusion of the distal popliteal artery (A) and absence of any named tibial vessels. (B) Postintervention angiogram with a 4.0 x 32-mm stent placement in the popliteal artery and a 3.5 x 32-mm stent placed in overlapping fashion extending into the posterior tibial artery. One-month ABIs normalized to 1.03 and claudication was relieved.

 


View larger version (17K):

[in a new window]
 
Figure 4 Box and whisker plot for the entire cohort, depicting the resting ankle brachial index (ABI) before (pre) and after (post) intervention. *p ≤ 0.0001 for improvement in ABI from baseline.

 


View larger version (17K):

[in a new window]
 
Figure 5 Box and whisker plot for patients with critical limb ischemia (CLI), depicting resting ankle brachial index (ABI) before (pre) and after (post) intervention. *p ≤ 0.0001 for improvement in ABI from baseline.

 


View larger version (16K):

[in a new window]
 
Figure 6 Box and whisker plot for patients with severe lifestyle-limiting claudication and jeopardized single-vessel runoff, depicting resting ankle brachial index (ABI) before (pre) and after (post) intervention. *p ≤ 0.0001 for improvement in ABI from baseline.

 


View larger version (17K):

[in a new window]
 
Figure 7 Qualitative improvement in baseline symptoms for the entire cohort. *p ≤ 0.0001 for improvement from baseline. There were no significant changes between one month and six months.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2004 by the American College of Cardiology Foundation.